Abstract:Background: Metabolic dysregulation following sepsis can significantly compromise patient prognosis by altering immune-inflammatory responses. Despite its clinical relevance, the exact mechanisms of this perturbation are not yet fully understood. Methods: Single-cell RNA sequencing (scRNA-seq) was utilized to map the immune cell landscape and its association with metabolic pathways during sepsis. This study employed cell-cell interaction and phenotype profiling from scRNA-seq data, along with pseudotime trajectory analysis, to investigate neutrophil differentiation and heterogeneity. By integrating scRNA-seq with Weighted Gene Co-expression Network Analysis (WGCNA) and machine learning techniques, key genes were identified. These genes were used to develop and validate a risk score model and nomogram, with their efficacy confirmed through Receiver Operating Characteristic (ROC) curve analysis. The model's practicality was further reinforced through enrichment and immune characteristic studies based on the risk score and in vivo validation of a critical gene associated with sepsis. Results: The complex immune landscape and neutrophil roles in metabolic disturbances during sepsis were elucidated by our in-depth scRNA-seq analysis. Pronounced neutrophil interactions with diverse cell types were revealed in the analysis of intercellular communication, highlighting pathways that differentiate between proximal and core regions within atherosclerotic plaques. Insight into the evolution of neutrophil subpopulations and their differentiation within the plaque milieu was provided by pseudotime trajectory mappings. Diagnostic markers were identified with the assistance of machine learning, resulting in the discovery of PIM1, HIST1H1C, and IGSF6. The identification of these markers culminated in the development of the risk score model, which demonstrated remarkable precision in sepsis prognosis. The model's capability to categorize patient profiles based on immune characteristics was confirmed, particularly in identifying individuals at high risk with suppressed immune cell activity and inflammatory responses. The role of PIM1 in modulating the immune-inflammatory response during sepsis was further confirmed through experimental validation, suggesting its potential as a therapeutic target. Conclusion: The understanding of sepsis immunopathology is improved by this research, and new avenues are opened for novel prognostic and therapeutic approaches.

Unlocking the potential of senescence-related gene signature as a diagnostic and prognostic biomarker in sepsis: insights from meta-analyses, single-cell RNA sequencing, and in vitro experiments

Elucidating the molecular mechanisms of sepsis: Identifying key aging‐related biomarkers and potential therapeutic targets in the treatment of sepsis

Comprehensive analysis of senescence-associated genes in sepsis based on bulk and single-cell sequencing data

A Signature of Immune-Related Genes Correlating with Clinical Prognosis and Immune Microenvironment in Sepsis

Neutrophil-based single-cell sequencing combined with transcriptome sequencing to explore a prognostic model of sepsis

Identification of Potential Early Diagnostic Biomarkers of Sepsis

Identification of potential biomarkers and pathways for sepsis using RNA sequencing technology and bioinformatic analysis

Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis

POS-182 SDF4 IS A PROGNOSTIC FACTOR FOR 28-DAYS MORTALITY IN PATIENTS WITH SEPSIS VIA NEGATIVELY REGULATING ER STRESS

Developing transcriptomic signatures as a biomarker of cellular senescence

Identifying Six Chromatin Remodeling-related Genes As Diagnostic Biomarkers in Sepsis Using Bioinformatic Analyses

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Identification of the Diagnostic Signature of Sepsis Based on Bioinformatic Analysis of Gene Expression and Machine Learning

Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data

A hypoxia- and lactate metabolism-related gene signature to predict prognosis of sepsis: discovery and validation in independent cohorts

Bulk RNA Sequencing With Integrated Single-Cell RNA Sequencing Identifies BCL2A1 as a Potential Diagnostic and Prognostic Biomarker for Sepsis

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Construction of a NETosis-related gene signature for predicting the prognostic status of sepsis patients

Identification of apoptosis-immune-related gene signature and construction of diagnostic model for sepsis based on single-cell sequencing and bulk transcriptome analysis

Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis

Deciphering the immune-metabolic nexus in sepsis: a single-cell sequencing analysis of neutrophil heterogeneity and risk stratification